135 related articles for article (PubMed ID: 20450565)
1. [National survey of blood pressure control rate in Chinese hypertensive outpatients-China STATUS].
Hu DY; Liu LS; Yu JM; Yao CH;
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Mar; 38(3):230-8. PubMed ID: 20450565
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.
Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K;
Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115
[TBL] [Abstract][Full Text] [Related]
3. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
4. Current status of antihypertensive prescription and associated blood pressure control in Japan.
Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
[TBL] [Abstract][Full Text] [Related]
5. [A survey of factors influencing prognosis and control rate for patients with hypertension in mainland China].
Qi WH; Pan CY; Lin SY
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 May; 35(5):457-60. PubMed ID: 17711690
[TBL] [Abstract][Full Text] [Related]
6. [Reasons for not intensifying antihypertensive treatment to diabetes in some regions of China].
Guo QH; Pan CY; Qi WH; Lin SY;
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):240-4. PubMed ID: 18361834
[TBL] [Abstract][Full Text] [Related]
7. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
8. Current status and characteristics of hypertension treatment by primary physicians in Korea: data from Korean epidemiology study on hypertension (KEY study).
Kim KI; Kim Y; Kim HJ; Kang DH; Park JB; Choi DJ; Kim CH;
Am J Hypertens; 2008 Aug; 21(8):884-9. PubMed ID: 18483472
[TBL] [Abstract][Full Text] [Related]
9. [Blood pressure control and glucose metabolism status in hypertension specialty clinics in China].
Sun NL; Wang HY; Huo Y
Zhonghua Nei Ke Za Zhi; 2013 Aug; 52(8):654-8. PubMed ID: 24199880
[TBL] [Abstract][Full Text] [Related]
10. Gap between evidence and physicians' knowledge and practice regarding hypertension and its drug treatment: a survey in a Chinese city.
Wang WZ; Tang JL; Hu YH; An JG; Wang YL; Ren ZH; Zhang H; Griffiths S
Chin Med J (Engl); 2011 Apr; 124(8):1235-41. PubMed ID: 21543003
[TBL] [Abstract][Full Text] [Related]
11. Thailand diabetes registry project: prevalence of hypertension, treatment and control of blood pressure in hypertensive adults with type 2 diabetes.
Bunnag P; Plengvidhya N; Deerochanawong C; Suwanwalaikorn S; Kosachunhanun N; Benjasuratwong Y; Krittiyawong S; Leelawatana R; Pratipanawatr T; Ngarmukos C; Chetthakul T; Puavilai G; Mongkolsomlit S; Rawdaree P
J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S72-7. PubMed ID: 17715837
[TBL] [Abstract][Full Text] [Related]
12. [Care of hypertensive patients seen by cardiologists: results of the Snapshot Hypertension Registry].
Silber S; Richartz BM; Goss F; Haerer W; Glowatzki M; Schmieder RE
Dtsch Med Wochenschr; 2007 Nov; 132(46):2430-5. PubMed ID: 17987549
[TBL] [Abstract][Full Text] [Related]
13. Improvement of blood pressure control in hypertensive patients with renal diseases.
Ohta Y; Tsuruya K; Fujii K; Tokumoto M; Kanai H; Matsumura K; Tsuchihashi T; Hirakata H; Iida M
Hypertens Res; 2007 Apr; 30(4):295-300. PubMed ID: 17541207
[TBL] [Abstract][Full Text] [Related]
14. Hypertension audit in clinical practice based in Thailand (HABIT).
Buranakitjaroen P
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S57-65. PubMed ID: 21721429
[TBL] [Abstract][Full Text] [Related]
15. The quality of arterial hypertension treatment in cardiology service in Kosovo--a single center study.
Bajraktari G; Sylejmani X; Thaçi K; Elezi S; Ndrepepa G
Anadolu Kardiyol Derg; 2009 Apr; 9(2):96-101. PubMed ID: 19357050
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence, awareness, treatment and control of hypertension in Chinese adults].
Gu DF; Jiang H; Wu XG; Reynolds K; Gan WQ; Liu DH; Su SY; Duan XF; Huang GY; Whelton PK
Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Mar; 37(2):84-9. PubMed ID: 12839656
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure control in patients with chronic renal insufficiency in Spain: a cross-sectional study.
Marín R; Fernández-Vega F; Gorostidi M; Ruilope LM; Díez J; Praga M; Herrero P; Alcázar JM; Laviades C; Aranda P;
J Hypertens; 2006 Feb; 24(2):395-402. PubMed ID: 16508589
[TBL] [Abstract][Full Text] [Related]
18. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
19. Knowledge, awareness, behavior (KAB) and control of hypertension among urban elderly in western China.
Zhang X; Zhu M; Dib HH; Hu J; Tang S; Zhong T; Ming X
Int J Cardiol; 2009 Sep; 137(1):9-15. PubMed ID: 18691776
[TBL] [Abstract][Full Text] [Related]
20. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
